Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
KardioStatus logo — Better Living Through Biometrics

KardioStatus

Better Living Through Biometrics

Founded 2022 United States Providence, United States 1 employees Non Equity Assistance Biotechnology, Health Care

General Information

Company Name KardioStatus
Founded Year 2022
Location United States Providence, United States
Employees 1
Industries Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with KardioStatus. To contact KardioStatus, visit kardiostatus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KardioStatus compare?

A PDF of KardioStatus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KardioStatus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KardioStatus

KardioStatus is a software-as-a-medical-device (SaMD) developer with a focus on creating clinically actionable neural network-based algorithms for biologic authentication and medical-grade clinical diagnostic and therapeutic applications. Teaming up with Professor George Karniadakis of Brown University’s School of Engineering, KardioStatus is working on innovative biometric signal processing algorithms utilizing novel machine learning architectures for precise classification and medical forecasting from wearable clinical biometrics. Specifically, the company's technology is initially targeting the classification and prediction of physiologic and behavioral states based on single-lead continuous electrocardiography, with potential applications extending to medicine, athletics, public health, and the military. Founded in 2022 and headquartered in the United States, KardioStatus is positioned at the intersection of biotechnology and healthcare. Despite no public records of its latest investment, the company’s approach to leveraging cutting-edge technology in enhancing human performance and advancing medical diagnostics presents an intriguing opportunity for potential venture capital consideration.

No funding data available for KardioStatus yet.

FAQ About KardioStatus

Better Living Through Biometrics
KardioStatus was founded in 2022.
KardioStatus is headquartered in Providence, United States.
KardioStatus operates in Biotechnology and Health Care.
KardioStatus has approximately 1 employees.

We're actively collecting intelligence on KardioStatus.

Source: BounceWatch company record for KardioStatus, https://bouncewatch.com/company/kardiostatus, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout